Has Lawrence Buono received payments from drug or device companies?

Yes. Drug and device makers reported $2,764 in general payments to Lawrence Buono across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Buono did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Buono come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Buono

Ophthalmology · Southold, NYNPI 1871546192

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,012 and has fallen 78.9% since, to $213 in 2023.

$2,764in general payments, 2019–2025

Across 86 payments — averaging $32.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$563
Amgen$561
Alcon$375
Biogen$176
Mallinckrodt Hospital Products Inc.$172
Mallinckrodt Enterprises LLC$152
plus $766 from 13 others

What the payments were for

Food & beverage$2,764100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	18	$563
Amgen	16	$561
Alcon	7	$375
Biogen	2	$176
Mallinckrodt Hospital Products Inc.	7	$172
Mallinckrodt Enterprises LLC	6	$152
NEW World Medical,inc.	2	$148
Novartis	8	$148
Glaukos Corporation	2	$138
Kala Pharmaceuticals, Inc.	7	$121
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$45
Johnson & Johnson Surgical Vision, Inc.	2	$35
Bausch & Lomb Americas Inc.	1	$25
Biotissue Holdings Inc.	1	$22
Sun Pharmaceutical Industries Inc.	1	$22
Shire North American Group Inc	1	$17
AstraZeneca	1	$16
Eyevance Pharmaceuticals LLC	1	$15
Ivantis, Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,764 in reported general payments places this provider in the 65th percentile of 1,587 ophthalmology providers in New York.

See all ophthalmology providers in New York →

Other ophthalmology in Southold

David RubaltelliBrooklyn$8.9M
Nathan RadcliffeNew York$2.1M
Richard SpaideNew York$1.7M
Eric DonnenfeldGarden City$1.4M
Marguerite McDonaldOceanside$893K
Joshua YoungNew York$814K
David KleinmanRochester$730K
Jonathan JonischGreat Neck$726K
Joseph PanarelliNew York$541K
Eric RosenbergNew York$434K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →